The Vice President of Clinical Operations will provide end-to-end operational leadership for clinical programs, overseeing current Phase 1/2 studies and the strategic planning for global Phase 3 registrational trials. This role involves managing CROs, optimizing site performance through data-driven insights, and ensuring high-quality execution across all clinical development milestones.
The Senior Director provides Sponsor-level leadership for inspection readiness and GCP compliance across the clinical development portfolio. They proactively identify operational gaps, manage cross-functional remediation plans, and ensure clinical trial processes meet regulatory standards.
The HR Generalist will manage end-to-end HR operations, including onboarding, offboarding, and HRIS data maintenance. They will also oversee benefits administration, leave management, and provide support for talent acquisition tasks.
The Senior Manager of Quality will own and evolve the company's Quality Management System while driving a culture of quality across the organization. They will lead internal and external audits, manage regulatory compliance, and partner cross-functionally to build robust quality foundations.
The Director will build and lead the company's ethics, compliance, and regulatory strategy functions from the ground up. They will serve as the primary subject matter expert, managing agency interactions, internal audits, and data governance frameworks.
The Clinical Trial Manager will independently lead the end-to-end operational execution of Phase II-III global clinical trials. This includes managing CRO relationships, ensuring regulatory compliance, and overseeing study budgets and documentation.
Develop and deploy deep learning models to predict signaling effects of therapeutic interventions and design experiments to validate systems biology models. Collaborate with cross-functional teams to address complex biological problems and present research findings to diverse audiences.
The role involves developing and deploying innovative AI models for antibody drug design while partnering with cross-functional teams to optimize therapeutic design pipelines. You will analyze validation results to iteratively improve methodologies and publish high-impact research to advance the company's position in the field.
